Larson Financial Group
MIRM icon

Larson Financial Group’s Mirum Pharmaceuticals MIRM Stock Holding History

Larson Financial Group’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$18.4K Buy
215
+86
+67% +$8.97K ﹤0.01% 2167
2026
Q2 		$15.1K Sell
129
-12
-9% -$1.2K ﹤0.01% 2169
2026
Q1 		$13K Buy
141
+6
+4% +$564 ﹤0.01% 2090
2025
Q4 		$10.7K Buy
135
+5
+4% +$359 ﹤0.01% 2086
2025
Q3 		$9.5K Buy
130
+127
+4,233% +$8.07K ﹤0.01% 2040
2025
Q2 		$153 Buy
+3
New +$134 ﹤0.01% 3107

Other funds holding MIRM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 20.64% 1-Year Est. Return

Larson Financial Group's MIRM Position: Q3 2026 in Review

Larson Financial Group increased its Mirum Pharmaceuticals (MIRM) stake by 67% in Q3 2026, buying an estimated $8.97K and bringing the position to 215 shares worth $18.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2167.

Larson Financial Group first reported a position in MIRM in Q2 2025 and has held it in 6 quarters since. 187 funds tracked by Wall St. Rank hold MIRM as of Q3 2026.

  • Larson Financial Group held 215 shares of Mirum Pharmaceuticals worth $18.4K as of Q3 2026.
  • Larson Financial Group bought 86 Mirum Pharmaceuticals shares in Q3 2026, an estimated $8.97K.
  • Mirum Pharmaceuticals made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #2167 holding.
  • Larson Financial Group first reported a position in Mirum Pharmaceuticals in Q2 2025 and has held it in 6 quarters since.
  • 187 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q3 2026.

Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.